Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer

Digestive Surgery

Volumn 28, Issue 4, 2011, Pages 252-257

  Aoyagi, Tomoyoshi ^a   Shuto, Kiyohiko ^a   Okazumi, Shinichi ^a   Shimada, Hideaki ^a,b   Kazama, Toshiki ^a   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apparent diffusion coefficient; Chemoradiotherapy; Diffusion weighted imaging; Esophageal cancer; Magnetic resonance imaging; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ESOPHAGUS TUMOR; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 79957960722     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000328770     Document Type: Article

References (25)

1. Kassam Z, Lockwood G, O'Brien C, Brierley J, Swallow C, Oza A, et al: Conformal radiotherapy in the adjuvant treatment of gastric cancer: review of 82 cases. Int J Radiat Oncol Biol Phys 2006; 65: 713-719. (Pubitemid 43795861)
2. Kim MK, Cho KJ, Kwon GY, Park SI, Kim YH, Kim JH, et al: ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer. Eur J Cancer 2008; 44: 54-60. (Pubitemid 350256935)
3. Ishibashi Y, Hanyu N, Nakada K, Suzuki Y, Yamamoto T, Takahashi T, et al: Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma. Eur J Cancer 2003; 39: 1409-1415. (Pubitemid 36773784)
4. Hironaka S, Hasebe T, Kamijo T, Ohtsu A, Boku N, Yoshida S, et al: Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy. Clin Cancer Res 2002; 8: 124-130. (Pubitemid 34101467)
5. Miyata H, Doki Y, Shiozaki H, Inoue M, Yano M, Fujiwara Y, et al: CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 2000; 6: 4859-4865. (Pubitemid 32110430)
6. Shimada H, Hoshino T, Okazumi S, Matsubara H, Funami Y, Nabeya Y, et al: Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. Br J Cancer 2002; 86: 552-557. (Pubitemid 34185091)
7. Weber WA: Positron emission tomography as an imaging biomarker. J Clin Oncol 2006; 24: 3282-3292. (Pubitemid 46622068)
8. Weber WA, Figlin R: Monitoring cancer treatment with PET/CT: does it make a difference? J Nucl Med 2007; 48(suppl 1):36S-44S. (Pubitemid 47604941)
9. Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, Blackstock W: Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol 1997; 18: 1057-1072. (Pubitemid 30412127)
10. Shukla-Dave A, Poptani H, Loevner LA, Mancuso A, Serrai H, Rosenthal DI, et al: Prediction of treatment response of head and neck cancers with 31 P-MR spectroscopy from pretreatment relative phosphomonoester levels. Acad Radiol 2002; 9: 688-694. (Pubitemid 34568804)
11. Thukral A, Thomasson DM, Chow CK, Eulate R, Wedam SB, Gupta SN, et al: Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab-initial experience. Radiology 2007; 244: 727-735. (Pubitemid 47292083)
12. Hayano K, Okazumi S, Shuto K, Matsubara H, Shimada H, Nabeya Y, et al: Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. Oncol Rep 2007; 18: 901-908.
13. Patterson DM, Padhani AR, Collins DJ: Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008; 5: 220-233. (Pubitemid 351493681)
14. Hein PA, Kremser C, Judmaier W, Griebel J, Pfeiffer KP, Kreczy A, et al: Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003; 45: 214-222. (Pubitemid 36197717)
15. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A: Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003; 179: 641-649. (Pubitemid 37101649)
16. Galban CJ, Mukherji SK, Chenevert TL, Meyer CR, Hamstra DA, Bland PH, et al: A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009; 2: 184-190.
17. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, et al: Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360: 307-308. (Pubitemid 34874724)
18. Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, et al: Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 2006; 16: 2637-2643. (Pubitemid 44823917)
19. Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, et al: Early detection of response to radiation therapy in patients with brain malignancies using conventional and high B-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003; 21: 1094-1100. (Pubitemid 46594139)
20. Sakurada A, Takahara T, Kwee TC, Yamashita T, Nasu S, Horie T, et al: Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 2009; 19: 1461-1469.
21. Aoyagi T, Shuto K, Okazumi S, Shimada H, Nabeya Y, Kazama T, Matsubara H: Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging. Exp Ther Med 2010; 1: 847-851.
22. Sobin LH, Wittekind C: TNM: Classification of Malignant Tumours, ed 6. New York, Wiley-Liss, 2002.
23. Nabeya Y, Ochiai T, Matsubara H, Okazumi S, Shiratori T, Shuto K, et al: Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. Dis Esophagus 2005; 18: 388-397. (Pubitemid 43904767)
24. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
25. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M: Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): technical improvement using free-breathing, STIR and high-resolution 3D display. Radiat Med 2004; 22: 275-282. (Pubitemid 39264807)